Navigating a New Reality: Commercial Strategy and COVID-19 - a podcast by Business Talent Group

As pharma and biopharma researchers race to develop treatments for COVID-19, commercial leaders must prepare now to ensure success in the market. Independent biopharma consultant Marc Cooley—who helps companies bring commercial planning efforts into the R&D process—joins us to discuss the commercial considerations that life science companies should keep in mind as they develop COVID-19 vaccines and therapies.

---

Hosted on Acast. See acast.com/privacy for more information.

Further episodes of BTG Insights on Demand

Further podcasts by Business Talent Group

Website of Business Talent Group